Skip to main content
. 2024 Apr 18;15:1382520. doi: 10.3389/fimmu.2024.1382520

Figure 6.

Figure 6

The correlations between YBXs score and stemness and immunogenicity, as well as the predictive efficacy of YBXs score in immunotherapy cohorts. (A) The correlations between YBXs score and RNAss, DNAss, TMB, and MSI (*p < 0.05). (B) The Kaplan–Meier survival analyses of YBXs score in GSE91061, IMvigor210, and GSE61676 cohorts. (C) Results of chi-square test between responsiveness and YBXs groups in GSE91061, IMvigor210, and GSE61676 cohorts. nCR, non-complete response; pCR, pathologic complete response; SD, stable disease; PD, progressive disease.